Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis // Int. J. Mol. Sci. 2017. Vol. 18. N. 3. P. 606. DOI: https://doi.org/10.3390/ijms18030606.
Ogawa R., Mitsuhashi K., Hyakusoku H., Miyashita T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months // Plast. Reconstr. Surg. 2003. Vol. 111. N. 2. P. 547–553.
Omo-Dare P. Yoruban contributions to the literature on keloids // J. Natl Med. Assoc. 1973. Vol. 65. N. 5. P. 367–406.
Robert R., Meyer W., Bishop S. et al. Disfiguring burn scars and adolescent self-esteem // Burns. 1999. Vol. 25. N. 7. P. 581–585. DOI: https://doi.org/10.1016/s0305-4179(99)00065-0.
Roques C., Teot L., Frasson N., Meaume S. PRIMOS: an optical system that produces three- dimensional measurements of skin surfaces // J. Wound Care. 2003. Vol. 12. N. 9. P. 362–364.
Roseborough I.E., Grevious M.A., Lee R.C. Prevention and treatment of excessive dermal scarring // J. Natl Med. Assoc. 2004. Vol. 96. N. 1. P. 108–116.
Rusciani L., Rossi G., Bono R. Use of cryotherapy in the treatment of keloids // J. Dermatol. Surg. Oncol. 1993. Vol. 19. N. 6. P. 529–534. DOI: https://doi.org/10.1111/j.1524-4725.1993.tb00386.x. PMID: 8509514.
Shaheen A., Khaddam J., Kesh F. Risk factors of keloids in Syrians // BMC Dermatol. 2016. Vol. 16. N 1. P. 13. DOI: https://doi.org/10.1186/s12895-016-0050-5.
Shin J.Y., Lee J.W., Roh S.G. et al. A comparison of the effectiveness of triamcinolone and radiation therapy for ear keloids after surgical excision: a systematic review and meta-analysis // Plast. Reconstr. Surg. 2016. Vol. 137. N. 6. P. 1718–1725. DOI: https://doi.org/10.1097/PRS.0000000000002165. PMID: 27219228.
Sproat J.E., Dalcin A., Weitauer N., Roberts R.S. Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment // Plast. Reconstr. Surg. 1992. Vol. 90. N. 6. P. 988–992. PMID: 1448534.
Steinbrech D.S., Mehrara B.J., Chau D. et al. Hypoxia upregulates VEGF production in keloid fibroblasts // Ann. Plast. Surg. 1999. Vol. 42. N. 5. P. 514–519.
Sun L.M., Wang K.H., Lee Y.C. Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study // Arch. Dermatol. Res. 2014. Vol. 306. N. 9. P. 803–808. DOI: https://doi.org/10.1007/s00403-014-1491-5.
Thorn I. Ueber spontanes keloid // Arch. Klin. Chir. 1895. Vol. 51. P. 618–636.
Tredget E.E., Wang R., Shen Q. et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo // J. Interferon Cytokine Res. 2000. Vol. 20. N. 2. P. 143–151. DOI: https://doi.org/10.1089/107999000312540. PMID: 10714549.
Unna PG. The Histopathology of the Diseases of the Skin. New York: Macmillan, 1896. 1205 p.
Van de Kar A.L., Kreulen M., van Zuijlen P.P., Oldenburger F. The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: a prospective clinical outcome study // Plast. Reconstr. Surg. 2007. Vol. 119. N. 7. P. 2248–2254.
Weinhammer A.P., Shields B.E., Keenan T. Intralesional corticosteroid-induced hypopigmentation and atrophy // Dermatol Online J. 2020. Vol. 26. N. 1. Article ID 13030/qt0bj81707. PMID: 32155037.
Yeong E.K., Mann R., Engrav L.H. et al. Improved burn scar assessment with use of a new scar-rating scale // J. Burn Care Rehabil. 1997. Vol. 18. P. 353–355.
Young V.L., Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys // Plast. Reconstr. Surg. 2009. Vol. 124. N. 1. P. 256–265. DOI: https://doi.org/10.1097/PRS.0b013e3181a80747.